The third module of the EFCCA Academy offering specialized training for IBD patients, took place on 25 January 2021 via the EFCCA online learning platform.
This module entitled “Breaking the myths around clinical trials” was presented by Prof. Ariel Liebert and speakers from Roche.
Prof. Ariel Liebert from the Department of Gastroenterology and Nutrition Disorders, Nicolaus Copernicus University in Toruń (Poland), taught about Clinical trials guidelines, benefits and risks related to participation, the study drug, medical care in progress, participant’s insurance, what to ask before making a decision and finished his presentation by talking about the most common myths around clinical studies.
A group of speakers from Roche covering a broad range of functions within the organisation and sharing their experience as part of the different role, such as Stefanie Derzsi – Patient Partnership Department, KT Park - Research and Development Department, Amanda Tatro - Medical Department, Jo Phipps - Regulatory Department and Laura Pope - Access Department, shed light in an interactive discussion on how industry is interacting with different stakeholders as part of the drug development process.
For more information about the EFCCA Academy go to: https://www.efcca.org/en/clinical-trials-training